Planned sales, announced before they happen
0 trading plans running, 11 Form 144 notices for $70.5M
Plans running now
0
none adopted and not yet ended or expired
What CAH's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Trading plans
Plans adopted or ended
| Insider | What | Date | Shares | Runs to | Reported in |
|---|---|---|---|---|---|
| Deborah L. Weitzman Chief Executive Officer, Pharmaceutical Segment |
Adopted 10b5-1 plan | Aug 28, 2023 | up to 27,642 | 445 days | 10-Q Nov 3, 2023 |
What the company wroteDuring the three months ended September 30, 2023, Deborah L. Weitzman, Chief Executive Officer, Pharmaceutical Segment, adopted a Rule 10b5-1 sales plan. Adopted on August 28, 2023, Ms. Weitzman's plan provides for the sale of up to 9,000 common shares and the exercise of vested stock options and the associated sale of up to 27,642 common shares through November 15, 2024. The plan was adopted during an open trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and our policies regarding insider transactions. | |||||
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 4, 2023.
Form 144
Notices of planned sales
| Filed | Seller | Shares | Value | Shares came from | 10b5-1 plan | Form 4 sales after |
|---|---|---|---|---|---|---|
| Aug 19, 2026 | Mary Scherer Officer |
2,302 | $546K | Performance Unit Vest; Restricted Stock Vest | none given | 2,302 shares from Aug 19, 2026 |
| Aug 18, 2026 | Aaron Alt Officer |
42,000 | $9.9M | Performance Unit Vest; Restricted Stock Vest | none given | 42,000 shares from Aug 18, 2026 |
| Aug 18, 2026 | Michelle Greene Officer |
11,650 | $2.7M | Performance Unit Vest; Restricted Stock Vest | none given | 11,650 shares from Aug 18, 2026 |
| Aug 18, 2026 | Deborah Weitzman Officer |
7,354 | $1.7M | Restricted Stock Vest | none given | 7,354 shares from Aug 18, 2026 |
| Aug 18, 2026 | Jessica Mayer Officer |
29,436 | $7.0M | Performance Unit Vest; Restricted Stock Vest | none given | 29,436 shares from Aug 18, 2026 |
| Aug 18, 2026 | Stephen Mason Officer |
35,000 | $8.3M | Performance Unit Vest; Restricted Stock Vest | none given | 35,000 shares from Aug 18, 2026 |
| Aug 18, 2026 | Jason Hollar Officer |
124,529 | $29.4M | Performance Unit Vest; Restricted Stock Vest | none given | 124,529 shares from Aug 18, 2026 |
| Jun 8, 2026 | Gregory Kenny Former Director |
43,542 | $8.9M | Restricted Stock Vesting | none given | none found |
| Feb 27, 2026 | Michelle Greene officer |
2,746 | $627K | Restricted stock vest | none given | none found |
| Feb 18, 2026 | Aaron Alt Officer |
2,328 | $525K | Restricted Stock Vesting | none given | none found |
| Feb 6, 2026 | Patricia Hemingway Hall Director |
4,000 | $919K | Board Compensation; Board compensation | none given | none found |
Show the other 3 notices
From the Form 144 XML filed with the SEC, since Feb 6, 2026. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.